ACTRN12617001571369
Not yet recruiting
Not Applicable
Effect of Stereotactic ablative body radiotherapy for Unresectable Pancreatic cancer with Endoscopic ultrasound inserted fiducial markers and concuRrent chemotherapy on survival rates: SUPER trial.
ConditionsPancreatic cancer tumours
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic cancer tumours
- Sponsor
- Royal Adelaide Hospital
- Enrollment
- 250
- Status
- Not yet recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
Completed
Not Applicable
The efficacy of stereotactic body radiation therapy for unresectable hepatocellular carcinoma: a single institution phase II studyKCT0000625Asan Medical Center50
Recruiting
Phase 2
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non-small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.early non-small cell lung cancerlung metastasessmall cell lung cancerlung metastasesSBRT lungFlattening filter freeFFFTCTR20171127003none138
Completed
Not Applicable
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.JPRN-UMIN000051712Yokohama City University Medical Center
Completed
Phase 2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20